Cite
HARVARD Citation
Coates, L. et al. (n.d.). FRI0502 Ixekizumab reduces disease activity in active psoriatic arthritis patients who had previous inadequate response to tumour necrosis factor-inhibitors. Annals of the rheumatic diseases. p. 679. [Online].